TCV-309 is an inhibitor of platelet activating factor (PAF). TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. TCV-309 attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. TCV-309 inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
Molekulargewicht:
656.52
CAS Nummer:
[131311-25-6]
Formel:
C30H34BrN5O7
Target-Kategorie:
Others
T28933
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten